Documents

in page functions

Searching... One moment please

Searching... One moment please

Searching... One moment please

Searching... One moment please

Searching... One moment please

Searching... One moment please

01 December 2010

GAVI Alliance monitoring and evaluation framework and strategy 2011-2015

The Monitoring and Evaluation Framework and Strategy is designed to contribute to meeting the GAVI Alliance’s diverse information needs, including those related to internal business processes, support to countries and overall effectiveness, efficiency and impact.

01 December 2010

GAVI Alliance Strategy and Business Plan 2011-2015

This GAVI Alliance Business Plan 2011-2015 describes the actions to be undertaken to achieve the 2011-2015 Strategy, while also laying out the context and challenges for the coming years.

29 October 2010

Baseline Study for pneumococcal vaccine AMC

The goal of the AMC baseline study was to establish the environment prior to the AMC with baseline estimates for a selection of indicators related to the objectives of the AMC and to model counterfactual scenarios to ascertain the potential impact of the AMC vis-a-vis traditional financial and procurement strategies.

29 October 2010

AMC Baseline Study

The AMC Baseline Study presents an innovative new approach to public health funding as a way of stimulating and accelerating the development and manufacture of vaccines for developing countries.

01 October 2010

Evaluation Advisory Committee report to the Board on the Second GAVI Evaluation

The Committee's overall assessment is that this is a credible and useful evaluation. The evaluation has yielded a number of important insights that will prove useful to the Board and Alliance as it prepares for and then implements its new strategy for the 2011-15 period.

13 September 2010

Supporting Paper 5: Progress against recommendations made by the Phase I Evaluation

Table presenting the key recommendations made by the Phase 1 evaluation and the GAVI Secretariat response. In addition, CEPA has interviewed Secretariat colleagues to understand progress made to date against these recommendations, which is noted in the final column labelled ‘implementation progress’.

13 September 2010

Supporting Paper 4.1: Bangladesh country study report

The report provides contextual information on Bangladesh’s health and immunisation sector, and assesses the results and value add of GAVI programs in the country from the country stakeholders’ perspective.

13 September 2010

Supporting Paper 10.3: SG4 report annexes

Supporting paper 10.3 of the second GAVI evaluation.

13 September 2010

Supporting Paper 1: Bibliography

Bibliography to the second GAVI evaluation.

13 September 2010

Second GAVI evaluation: Strategic Goal 4 report

This report provides the detailed analysis and evaluation material for Strategic Goal (SG) 4 in GAVI Phase II (2006-2010). GAVI's SG4 is: "to increase and assess the added value of GAVI as a public private global health partnership through improved efficiency, increased advocacy and continued innovation."

Searching... One moment please

Searching... One moment please

Searching... One moment please

1 - 10 of 36 matches Page: 1 2 3 
 



close icon

modal window here